Duke, MIT and Stanford each operationalise the same federal research-misconduct standard through different institutional machinery. Duke routes allegations to a Misconduct Review Officer and a 24-hour Integrity Line; MIT centralises review under its Vice President for Research; Stanford assigns first-line assessment to school deans under a Research Policy Handbook chapter revised effective 1 January 2026. All three exist to satisfy one governing rule: the Public Health Service Policy on Research Misconduct.
The federal policy on research misconduct — codified at 42 C.F.R. Part 93 and enforced by the HHS Office of Research Integrity (ORI) — defines research misconduct as fabrication, falsification, or plagiarism (FFP) in proposing, performing, or reviewing research, or in reporting research results. Every US university that accepts Public Health Service funding, including Duke, MIT and Stanford, must maintain an institutional policy that meets this baseline, then layers its own governance, reporting channels, and disciplinary structure on top.
- How does Duke’s research misconduct policy define and handle allegations?
- How does MIT structure its research misconduct procedures?
- What changed in Stanford’s research misconduct policy for 2026?
- How do Duke, MIT and Stanford compare side by side?
- Common questions on federal and institutional research misconduct policy
- What this means for research administrators
How does Duke’s research misconduct policy define and handle allegations?
Duke’s research misconduct policy is set out in the Duke University Policy and Procedures Governing Misconduct in Research, part of the Faculty Handbook and last updated in May 2023. Allegations are directed to a designated Misconduct Review Officer (MRO), or to a department chair, division chief, or dean, who must promptly forward the matter to the MRO.
Duke also operates an Integrity Line — a 24-hour, anonymous telephone hotline (1-800-826-8109) — so that reporters can raise concerns without disclosing their identity. This dual-channel design (a named institutional officer plus an anonymous hotline) reflects a broader reform effort: Duke’s policy was revised to extend coverage beyond faculty to research staff, alongside wider research-integrity reforms following a 2019 case in which the university agreed to a $112.5 million False Claims Act settlement over fabricated data in federally funded pulmonary research, as reported by Science. That episode is a documented driver of the university folding staff explicitly into the policy’s scope, according to case-study materials prepared for the Council on Governmental Relations (COGR).
How does MIT structure its research misconduct procedures?
MIT’s framework sits in MIT Policies and Procedures §10.1, “Procedures for Dealing with Misconduct in Research and Scholarship,” last updated 10 December 2025. Oversight is centralised: every allegation, wherever it is first raised, must be conveyed promptly to the Vice President for Research (VPR), MIT’s designated Research Integrity Officer.
MIT’s definition tracks the federal FFP triad — fabrication (making up data), falsification (manipulating materials or altering results), and plagiarism (appropriating another’s ideas or words without credit) — but adds a fourth category not found in the core PHS definition: deliberate interference, meaning intentionally causing material harm to another’s research, such as damaging equipment or deleting data. MIT’s policy also explicitly excludes self-plagiarism (text recycling) and authorship or credit disputes among former collaborators from the definition of misconduct, mirroring longstanding ORI guidance on plagiarism.
What changed in Stanford’s research misconduct policy for 2026?
Stanford’s governing chapter, Research Policy Handbook (RPH) 1.7, “Research Misconduct: Policy on Allegations, Investigations, and Reporting,” dates originally to 3 February 1983 but carries a current version effective 1 January 2026. The update aligns Stanford’s procedures with the 2024 Final Rule amending 42 C.F.R. Part 93 — the same federal regulation that governs Duke and MIT.
Two provisions distinguish Stanford’s approach. First, the “Six-Year Rule” (42 C.F.R. §93.104): research misconduct allegations are only actionable if the conduct occurred within six years of the date Stanford or a federal agency received the allegation, subject to a “subsequent use” exception (if the respondent later cited or republished the disputed material) and a “public health and safety” exception. Second, first-line responsibility sits with the school dean, who must assess an allegation and, if it meets the definition, immediately open an inquiry and notify the Dean of Research — a more devolved structure than MIT’s single VPR intake point.
How do Duke, MIT and Stanford compare side by side?
The table below sets the three institutional policies against each other and against the federal baseline they all must satisfy.
| Institution | Governing document | First-line authority | Reporting channel | Misconduct definition |
|---|---|---|---|---|
| Duke University | Policy and Procedures Governing Misconduct in Research (Faculty Handbook, updated May 2023) | Misconduct Review Officer | MRO, department chair/dean, or anonymous Integrity Line | FFP, per 42 C.F.R. Part 93; covers faculty and staff |
| MIT | MIT Policies and Procedures §10.1 (updated 10 Dec 2025) | Vice President for Research | Report to VPR, typically via supervisor or department head | FFP plus deliberate interference; excludes self-plagiarism and authorship disputes |
| Stanford University | Research Policy Handbook 1.7 (current version 1 Jan 2026; original 1983) | School dean, then Dean of Research | Report to school dean for initial assessment | FFP per 42 C.F.R. Part 93 (2024 Final Rule); six-year time limitation |
| Federal baseline | PHS Policy on Research Misconduct, 42 C.F.R. Part 93 | HHS Office of Research Integrity (ORI) | Institutional report to ORI after a finding | Fabrication, falsification, or plagiarism (FFP) |
All three institutions converge on the same two-stage process required by federal policy:
- An inquiry — a preliminary assessment of whether an allegation has substance and warrants formal review.
- An investigation — a full evidentiary examination that produces findings reported to ORI when federal funding is involved.
Common questions on federal and institutional research misconduct policy
What is the US federal research misconduct policy?
The US federal research misconduct policy is the Public Health Service Policy on Research Misconduct, codified at 42 C.F.R. Part 93 and enforced by ORI. It applies to fabrication, falsification, and plagiarism in proposing, performing, reviewing, or reporting PHS-supported research, and requires every recipient institution to maintain a compliant local policy.
What is 42 CFR Part 93 research misconduct?
42 C.F.R. Part 93 is the federal regulation setting the definitions, procedural standards, and reporting obligations that PHS-funded institutions — including Duke, MIT, and Stanford — must follow. A 2024 Final Rule to Part 93 took effect on 1 January 2026, updating provisions including the definition of plagiarism that institutions must now apply.
What are the three types of research misconduct?
The three federally recognised types are fabrication (inventing data or results), falsification (manipulating materials, equipment, or data so the research record is inaccurate), and plagiarism (using another’s ideas, processes, or words without credit). Honest error and legitimate differences of scientific opinion are explicitly excluded.
What constitutes research misconduct according to federal regulations?
A federal finding requires three elements together: a significant departure from accepted research practices, conduct committed intentionally, knowingly, or recklessly, and an allegation proven by a preponderance of the evidence. All three tests must be met before ORI or an institution can record a formal finding of misconduct.
What this means for research administrators
For research administrators, compliance officers, and institutional leaders, the practical lesson is that federal alignment does not mean procedural uniformity. Duke, MIT, and Stanford each satisfy 42 C.F.R. Part 93, yet route allegations through different first-line authorities — an MRO, a VPR, and a school dean respectively — and set different scope boundaries around staff coverage, deliberate interference, and time limitations. Institutions benchmarking their own research administration policy against peer practice should treat the federal rule as the floor, not the template, and expect further local revisions as the 2024 Final Rule to Part 93 continues to work through university policy cycles into 2026 and beyond.
Given that Stanford’s update took effect only this year and MIT revised its procedures in December 2025, institutional research misconduct policies are clearly still catching up to the federal 2024 Final Rule — administrators reviewing their own institution’s policy should confirm which version of 42 C.F.R. Part 93 it currently cites before assuming compliance.